7Baggers
 published on: 2025-09-20 14:28:46  khodrobank.com Sat, 20 Sep 2025 11:00:33 GMT
 acrivon therapeutics, inc. (nasdaq:acrv) short interest update  Defense World Sat, 20 Sep 2025 05:40:36 GMT
 acrivon therapeutics’ swot analysis: precision oncology stock at crossroads  Investing.com India Fri, 19 Sep 2025 01:52:57 GMT
 Citizens JMP Sticks to Its Buy Rating for Acrivon Therapeutics, Inc. (ACRV)  The Globe and Mail Thu, 18 Sep 2025 07:00:00 GMT
 published on: 2025-09-16 04:25:13  خودرو بانک Tue, 16 Sep 2025 00:56:53 GMT
 published on: 2025-09-09 18:21:35  Newser Tue, 09 Sep 2025 23:21:35 GMT
 Is Acrivon Stock Climbing Too High?  timothysykes.com Mon, 08 Sep 2025 13:19:00 GMT
 Nuveen LLC Invests $27,000 in Acrivon Therapeutics, Inc. $ACRV  Defense World Mon, 08 Sep 2025 07:20:26 GMT
 published on: 2025-09-05 14:38:56  Newser Fri, 05 Sep 2025 19:38:56 GMT
 Acrivon Therapeutics Highlights Synergy in Updated Presentation  TipRanks Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 02:39:13  Newser Thu, 04 Sep 2025 07:39:13 GMT

Acrivon Therapeutics, Inc.
(NASDAQ:ACRV) 

ACRV stock logo

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to specific medicine by utilizing its proteomics-based patient responder identification platform, Acrivon ...

Founded: 2018
Full Time Employees: 35
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends